The 2024 presidential election is approaching, bringing potential changes to the U.S. healthcare system regardless of whether Kamala Harris or Donald Trump wins. During a recent webinar, experts discussed how a Harris presidency would focus on antitrust enforcement and healthcare fraud, while a Trump presidency would likely offer more regulatory flexibility. Harris is likely to expand Medicaid and extend benefits, while Trump may increase work requirements and explore block grants. Both candidates support AI innovation in healthcare. Harris would work on drug pricing reform, negotiating Medicare drug prices and expanding the $35 insulin price cap, while Trump may focus on international reference pricing policies.
Source link
Where Trump & Harris Stand on Payers, AI, Drug Pricing and CMS
